Procaps Group - PROC Earnings per share for the trailing year

Procaps Group SA (PROC) - corporate logo

The EPS YoY TTM percentage change trend demonstrates profit dynamics, where the parameter has settled at 134.80. Procaps Group S.A. (PROC) is implementing autonomous logistics and AI-driven forecasting alongside maximum production line automation. Revenues are based on CDMO services for industry behemoths and the sale of generics in Latin America. The holding's stability and focus on innovation attract the region's leading technologists, guaranteeing them career growth.

procapsgroup.com (PROC): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

PROC (Procaps Group SA): analytical breakdowns and indicator data

- stock price and consensus target price:
Price procapsgroup.com|PROC - Analyst Consensus Forecast
- issuer market value details:
Market Value Procaps Group S.A.|PROC - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Procaps|PROC - Company Book Value|Market Value to Book Value procapsgroup.com|PROC - Aggregate Company Assets
- company total debt and liquidity indicators:
Aggregate Debt to Equity Procaps Group S.A.|PROC - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Procaps Group Corp|PROC - Company Debts|Debts to Book Value Procaps Group S.A.|PROC - Company Long-Term Debts|Company Current Liabilities Procaps|Quick Ratio procapsgroup.com
- net income and valuation ratios data:
PROC - Company Net Income|Forward Earnings Procaps Group S.A.|PROC - Price to Earnings Ratio|Market Cap to Projected Earnings Procaps Group|PROC - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Procaps Group S.A.|PROC - Operating profit EBITDA|Net earnings per share for the trailing year Procaps|PROC - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months procapsgroup.com|PROC - Earnings per share growth in current year|Expected net earnings per share growth next year Procaps Group S.A.
Initial company analysis:PROC, procapsgroup.com
Brand item of Procaps Group Corp

Procaps Group S.A. is integrating ESG standards into the production of encapsulated pharmaceuticals to optimize environmental costs. This indicator reflects the rolling year earnings per share (EPS) dynamics, capturing the rate of change in net profitability. The metric allows for an assessment of cost management efficiency and the business's ability to scale profits. It is critical for investors to distinguish a temporary downturn from a systemic profitability crisis. The 12-month EPS YoY history clearly demonstrates these phases.

Competitor analysis for Procaps Group S.A.

haleon.com - Earnings per share for the last four quarters|KVUE: Net earnings per share (EPS TTM)|Verona Pharma PLC - Earnings per share for the trailing year|MENS (Jyong Biotech Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ligand Corp LGND|Earnings per share for the last twelve months Amneal Pharmaceuticals (AMRX)|PRGO (perrigo.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Alvotech SA ALVO|LQDA (Liquidia Corp) - Earnings per one share for the last 12 months|GLPG - Earnings per share for the last twelve months|Earnings per share for the trailing year ANIP (ANI Pharmaceuticals Corp)|MannKind Corporation (MNKD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months amphastar.com (AMPH)|PCRX (Pacira BioSciences, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ARS Pharmaceuticals Inc (SPRY)|Net earnings per share (EPS TTM) TBPH|Net earnings per share (EPS TTM) Aquestive Corp (AQST)|Earnings per share for the last twelve months scPharmaceuticals SCPH|TECX (Tectonic Therapeutic Inc.) - Earnings per one share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters China SXT Pharmaceuticals SXTC|EPRX (eupraxiapharma.com) - Net earnings per share for the last 12 months|BioHarvest Sciences Inc - Earnings per share for the trailing year|EXOZ (eXoZymes Inc) - Net earnings per share (EPS TTM)|ORMP - Net earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Holdings, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months ABVC BioPharma Inc ABVC|Cumberland Corp (CPIX) - Net earnings per one share for the last twelve months|QNTM: Net earnings per share for the last 12 months|FGEN - Net earnings per share (EPS TTM)|Telomir Pharmaceuticals, Inc. (TELO) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months RANI (Rani Therapeutics Holdings, Inc.)|Net earnings per share for the last 12 months SNYR|RLYB: Earnings per share for the trailing year|Earnings per share for the last twelve months Lexaria Bioscience (LEXX)|Net earnings per share for the last four quarters pulmatrix.com|Pheton Holdings - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Aptorum Group Ltd (APM)|Lyra Therapeutics, Inc - Net earnings per share (EPS TTM)|IBO - Net earnings per share (EPS TTM)|TNFA (tnfpharma.com) - Net earnings per share for the last 12 months|YCBD - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PainReform|Auris Medical - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Lipella (LIPO)|OPTN (OptiNose Corp) - Earnings per share for the trailing year|Earnings per share for the last twelve months Pieris Pharmaceuticals PIRS|petrospharma.com (PTPI) - Net earnings per one share for the last twelve months|Qilian International Holding - Net earnings per share (EPS TTM)|Acelyrin Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months